These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2563798)

  • 1. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
    Bargman JM; Jones JE; Petro JM
    Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Koster AM; Monnens LA
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of recombinant human erythropoietin in children with chronic renal failure.
    Cakar N; Ekim M; Tümer N; Yalçinkaya F; Akar N; Onaran HO
    Int Urol Nephrol; 1997; 29(3):377-83. PubMed ID: 9285314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Contrib Nephrol; 1989; 76():112-20; discussion 120-1. PubMed ID: 2684515
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
    Huang TP; Lin CY
    Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.
    Stockenhuber F; Loibl U; Gottsauner-Wolf M; Jahn C; Manker W; Meisl TF; Balcke P
    Nephron; 1991; 59(3):399-402. PubMed ID: 1758528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers.
    Jensen JD; Madsen JK; Jensen LW; Pedersen EB
    J Am Soc Nephrol; 1994 Aug; 5(2):177-85. PubMed ID: 7993997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients.
    Nielsen OJ
    Pharmacol Toxicol; 1990 Feb; 66(2):83-6. PubMed ID: 2315268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T; Danielson BG; Wikström B
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
    Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P
    Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Lai PC; Wu MS; Huang JY; Huang CC; Leu ML
    Changgeng Yi Xue Za Zhi; 1994 Jun; 17(2):105-12. PubMed ID: 8069732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T
    Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G; Bailie GR; Clement C; Wong E
    Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intraperitoneal epoetin alfa in patients on peritoneal dialysis using an 8-hour "dry dwell" dosing technique.
    Taylor CA; Kosorok MR; Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1999 Oct; 34(4):657-62. PubMed ID: 10516346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations.
    Kampf D; Eckardt KU; Fischer HC; Schmalisch C; Ehmer B; Schostak M
    Nephron; 1992; 61(4):393-8. PubMed ID: 1501734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.